SCHEMBL20204057

SCHEMBL20204057

Cc1ccc(OCCCNC(=O)OC(C)(C)C)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.51
CA1 P00915 6/20 0.51
CA2 P00918 6/20 0.51
CA9 Q16790 6/20 0.51
STK17B O94768 1/20 0.46
STK17A Q9UEE5 1/20 0.46
TDP1 Q9NUW8 3/20 0.46
CCNC P24863 1/20 0.45
CDK8 P49336 1/20 0.45
GABRA5 P31644 1/20 0.44
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP3A4 P08684 1/20 0.43
SCN9A Q15858 1/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP1A1 P04798 1/20 0.43
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30131245 0.96 CA12 (0.50) CA12CA1CA2CA9STK17B
SCHEMBL23720472 0.86 CA12 (0.50) CA12CA1CA2CA9STK17B
SCHEMBL20173482 0.86 CA12 (0.50) CA12CA1CA2CA9STK17B
SCHEMBL16980667 0.86 CA1 (0.53) CA12CA1CA2CA9STK17B
SCHEMBL18530385 0.83 CA12 (0.50) CA12CA1CA2CA9STK17B
SCHEMBL16980508 0.82 CA12 (0.49) CA12CA1CA2CA9STK17B
SCHEMBL18289997 0.82 CA12 (0.49) CA12CA1CA2CA9STK17B
SCHEMBL18530389 0.82 CA12 (0.49) CA12CA1CA2CA9STK17B
SCHEMBL30564446 0.82 CA12 (0.49) CA12CA1CA2CA9STK17B
SCHEMBL528927 0.82 CA12 (0.52) CA12CA1CA2CA9STK17B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098305-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF BREAST CANCER EISAI R&D MANAGEMENT CO., LTD. (JP) 2018-05-31 WO disclosed